SCHEDULE: Tweardy Reports 3.4% Stake in TVARDI THERAPEUTICS
Beneficial Ownership Amendment
Samuel D. Tweardy files an amended Schedule 13G, reporting beneficial ownership of 3.4% of TVARDI THERAPEUTICS, INC. common stock.
Summary
- Samuel D. Tweardy beneficially owns 315,658 shares of TVARDI THERAPEUTICS, INC. common stock.
- This represents 3.4% of the company's outstanding common stock.
- The percentage is based on 9,373,433 shares of common stock outstanding as of August 7, 2025.
- The shares are held directly by the Samuel David Tweardy 2020 Gift Trust, for which Samuel D. Tweardy serves as trustee.
- Samuel D. Tweardy resigned as trustee of the Benjamin John Tweardy 2020 Gift Trust and the Daniel James Tweardy 2020 Gift Trust.
- The shares held by the trusts from which he resigned as trustee remain subject to a lock-up agreement dated December 17, 2024.
Sentiment
Score: 5
Explanation: The filing is a routine regulatory disclosure of beneficial ownership, specifically an amendment reflecting a change in the reporting person's trustee roles. It does not contain information that would typically be interpreted as positive or negative for the company's operational or financial performance, thus a neutral sentiment score is appropriate.
Future Outlook
NA
Industry Context
This filing is a standard regulatory disclosure regarding a change in beneficial ownership, common in the financial industry for publicly traded companies. It does not provide operational or strategic insights into TVARDI THERAPEUTICS's business or its position within the biotechnology or pharmaceutical industry.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Trustee | Samuel D. Tweardy | NA | NA | Resigned as trustee of Benjamin John Tweardy 2020 Gift Trust and Daniel James Tweardy 2020 Gift Trust. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Trustee Resignation | Samuel D. Tweardy resigned as trustee of the Benjamin John Tweardy 2020 Gift Trust and the Daniel James Tweardy 2020 Gift Trust. This impacts the beneficial ownership reporting for these specific trusts. | NA | This change primarily affects the reporting of beneficial ownership by Samuel D. Tweardy, as he no longer has dispositive power over the shares held by these two trusts for SEC reporting purposes. The shares themselves remain subject to a lock-up agreement. |
Related Party Transactions
- The Samuel David Tweardy 2020 Gift Trust, Benjamin John Tweardy 2020 Gift Trust, and Daniel James Tweardy 2020 Gift Trust are related parties through Samuel D. Tweardy's past and current trustee roles. Shares held by the latter two trusts are subject to a lock-up agreement with the Issuer.
Stakeholder Impact
- Shareholders: Provides updated information on a significant beneficial owner's stake and changes in their reported control over certain shares, which is relevant for understanding ownership structure.
- Regulatory Authorities: Fulfills SEC reporting requirements for beneficial ownership.
Key Dates
| Date | Description |
|---|---|
| 2024-12-17 | Date of lock-up agreement between each Trust and the Issuer. |
| 2025-07-07 | Date of event which requires filing of this statement. |
| 2025-08-05 | Date of signature for the Schedule 13G Amendment. |
| 2025-08-07 | Date as of which 9,373,433 shares of the Issuer's common stock were outstanding. |
Keywords
TVARDI THERAPEUTICS, Samuel D. Tweardy, Beneficial Ownership, Schedule 13G, Common Stock, Trustee Resignation, Lock-up Agreement
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.